Eli Lilly controversies - PDFSEARCH.IO - Document Search Engine

Eli Lilly controversies
Results: 42

#	Item
31	Gannett News Service February 13, 2013 Wednesday Drug makers must reveal payments to doctors BYLINE: Maureen Groppe, Gannett Washington Bureau SECTION: Pg. ARC LENGTH: 1396 words Add to Reading List Source URL: nationalpress.org Language: English - Date: 2014-03-14 17:08:31 Organic chemistry Pharmaceutical industry Eli Lilly Olanzapine Medical ethics Methadone American Medical Association Eli Lilly controversies David Healy Eli Lilly and Company Chemistry Pharmaceutical sciences
32	September 24, 2008 NEWS IS PROVIDED FOR YOUR USE AND INFORMATION WITHOUT ENDORSEMENT OR OPINION Article courtesy of Dr. Susan Rose, USC: By BENEDICT CAREY Add to Reading List Source URL: humansubjects.energy.gov Language: English - Date: 2012-08-29 10:11:01 Research Pharmaceutical industry Pharmacy Clinical trial Eli Lilly and Company Pfizer Eli Lilly controversies Aggregate Spend Pharmaceutical sciences Pharmacology Health
33	PRINCIPLES OF MEDICAL RESEARCH Preamble Eli Lilly and Company creates and delivers innovative medicines that enable people to live longer, healthier and more active lives. Lilly carefully conducts medical research to g Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-08-20 09:51:04 Medicine United States Eli Lilly controversies Eli Lilly and Company Indiana Eli Lilly
34	Principles of Medical Research Clinical Trial Registry Eli Lilly and Company is committed to principles of medical research that define the ethical conduct, funding, and communication of clinical research. Lilly conducts Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-08-20 09:51:07 Pharmaceutical industry Science Medical statistics Health research Eli Lilly and Company Clinical trials registry Clinical trial Medical research Eli Lilly controversies Health Research Clinical research
35	Principles of Medical Research Clinical Trial Registry Eli Lilly and Company is committed to principles of medical research that define the ethical conduct, funding, and communication of clinical research. Lilly conducts Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-08-20 09:51:05 Pharmaceutical industry Science Medical statistics Health research Eli Lilly and Company Clinical trials registry Clinical trial Medical research Eli Lilly controversies Health Research Clinical research
36	News Release Attorney General Robert E. Cooper, Jr. FOR IMMEDIATE RELEASE Jan. 15, 2009 #09-04 Add to Reading List Source URL: www.tn.gov Language: English - Date: 2011-07-20 17:29:36 Indiana Olanzapine Medicaid TennCare Eli Lilly Eli Lilly Eli Lilly controversies James Gottstein Eli Lilly and Company United States Medicine
37	7022 Federal Register / Vol. 65, No[removed]Friday, February 11, [removed]Notices 3724, Telephone[removed]–4824, Internet address: [removed]. Add to Reading List Source URL: www.fda.gov Language: English - Date: 2000-02-11 05:25:32 Pharmacology Health Patient safety Food and Drug Administration Therapeutics United States Public Health Service Medical prescription United States Department of Health and Human Services Eli Lilly controversies Pharmaceutical sciences Medicine Clinical pharmacology
38	NOTIFICATION OF PRODUCT TAMPERING May 4, 2002 Dear Pharmacy Professional, We would like to bring to your attention a situation involving tampering with Zyprexa� (olanzapine), indicated for the treatment of schizophren Add to Reading List Source URL: www.fda.gov Language: English Piperazines Chemistry Aspirin Pharmacology Eli Lilly controversies Eli Lilly and Company Organic chemistry Olanzapine
39	DNA Discovery Blue Lilly Brand PowerPoint template Add to Reading List Source URL: www.in.gov Language: English - Date: 2014-05-22 10:01:56 Eli Lilly Pharmaceutical industry Lilly Eli Lilly controversies Eli Lilly and Company Indiana United States
40	SEC Complaint: Eli Lilly and Company Add to Reading List Source URL: www.sec.gov Language: English - Date: 2012-12-20 13:58:44 United States Lilly Pharmaceutical industry Eli Lilly controversies Eli Lilly and Company Indiana Eli Lilly